ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32 | 0.0% | 905 | 0.0% | 0.00% | – |
| Q2 2023 | $32 | -100.0% | 905 | -58.7% | 0.00% | – |
| Q1 2022 | $101,000 | -39.2% | 2,192 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $166,000 | -62.3% | 2,655 | -50.0% | 0.00% | 0.0% |
| Q2 2021 | $440,000 | +25.0% | 5,310 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $352,000 | -84.3% | 5,310 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,241,000 | +509.0% | 5,310 | -37.7% | 0.00% | 0.0% |
| Q3 2020 | $368,000 | +1169.0% | 8,530 | +2032.5% | 0.00% | – |
| Q2 2020 | $29,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
| Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
| Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
| COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
| Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
| JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
| WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
| M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
| Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
| Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |